Tuberculosis Disease Associated with Suspected Contaminated Viable Bone Matrix Material Used in Surgical and Dental Procedures

Published: 07/20/2023

  • Centers for Disease Control and Prevention
Relevant To:
  • Ambulatory Surgical Centers,
  • Urgent Care,
  • Critical Access Hospitals,
  • Hospitals,
  • Office-Based Surgery,
  • Clinical Lab,
  • Rural Health Clinics

The U.S. Centers for Disease Control and Prevention (CDC) is working with state health departments, FDA, and Aziyo Biologics to respond to a new cluster of tuberculosis (TB) cases linked to suspected contaminated viable bone matrix material used primarily in spinal fusion back surgeries and dental surgeries.

These procedures used a single product lot of a viable bone matrix material manufactured by Aziyo Biologics (lot #TDS222820) with an expiration date of November 2, 2024. On July 13, 2023,

Sign Up for Free Trial